UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 85

Sortiert nach

14‐3‐3 Protein Signaling in Development and Growth Factor Responses

Current Topics in Developmental Biology, 2005, Vol.67, p.285-303

2005

Link zum Volltext

Verfügbarkeit prüfen

14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell Survival

The Journal of biological chemistry, 2009-05, Vol.284 (18), p.12080-12090

2009

Link zum Volltext

Verfügbarkeit prüfen

14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell SurvivalS

The Journal of biological chemistry, 2009-05, Vol.284 (18), p.12080-12090

2009

Link zum Volltext

Verfügbarkeit prüfen

14-3-3[zeta] coordinates adipogenesis of visceral fat

Nature communications, 2015-07, Vol.6, p.7671

2015

Link zum Volltext

Verfügbarkeit prüfen

14-3-3 Zeta is Required for Insulin Sensitivity and Glucose Homeostasis In Vivo

Canadian journal of diabetes, 2012-10, Vol.36 (5), p.S18-S19

2012

Link zum Volltext

Verfügbarkeit prüfen

14-3-3zeta Regulates Adipogenesis, Glucose Tolerance and Insulin Sensitivity in Mice

Canadian journal of diabetes, 2013-10, Vol.37, p.S9-S9

2013

Link zum Volltext

Verfügbarkeit prüfen

14-3-3ζ coordinates adipogenesis of visceral fat

Nature communications, 2015-07, Vol.6 (1), p.7671, Article 7671

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5283: Elucidating a novel role for inositol polyphosphate 4-phosphatase type II (INPP4B) in mediating chemoresistance in acute myeloid leukemia

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.5283-5283

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract A19: The selective targeting of cell survival pathways in leukemia

Cancer research (Chicago, Ill.), 2013-10, Vol.73 (19_Supplement), p.A19-A19

2013

Link zum Volltext

Verfügbarkeit prüfen

Abstract B158: Targeting cell survival pathways in glioblastoma

Molecular cancer therapeutics, 2011-11, Vol.10 (11_Supplement), p.B158-B158

2011

Link zum Volltext

Verfügbarkeit prüfen

Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors

Oncotarget, 2016-07, Vol.7 (30), p.47465-47478

2016

Link zum Volltext

Verfügbarkeit prüfen

Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production

PLoS genetics, 2013-02, Vol.9 (2), p.e1003222-e1003222

2013

Link zum Volltext

Verfügbarkeit prüfen

Associations Between Rheumatoid Arthritis Clinical Factors and Synovial Cell Types and States

Arthritis & rheumatology (Hoboken, N.J.), 2024-03, Vol.76 (3), p.356-362

2024

Link zum Volltext

Verfügbarkeit prüfen

Blocking of Cytokine Survival Signals along with Intense Bcr-Abl Kinase Inhibition May Eradicate CML Progenitor Cells

Blood, 2009-11, Vol.114 (22), p.3250-3250

2009

Link zum Volltext

Verfügbarkeit prüfen

CD123 (IL-3 Receptor α Chain) Neutralization by a Monoclonal Antibody Selectively Eliminates Human Acute Myeloid Leukemic Stem Cells

Blood, 2007-11, Vol.110 (11), p.161-161

2007

Link zum Volltext

Verfügbarkeit prüfen

Characterization of a Low Molecular Weight Isoform of IL-1 Receptor Antagonist

The Journal of immunology (1950), 1998-08, Vol.161 (4), p.1997-2003

1998

Link zum Volltext

Verfügbarkeit prüfen

The chromatin landscape of pathogenic transcriptional cell states in rheumatoid arthritis

Nature communications, 2024-05, Vol.15 (1), p.4650-25, Article 4650

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2018-09, Vol.70 (9), p.1470-1480

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial

Arthritis & rheumatology (Hoboken, N.J.), 2018-09, Vol.70 (9), p.1470-1480

2018

Link zum Volltext

Verfügbarkeit prüfen

The Clinical Efficacy and Safety of Baminercept, a Lymphotoxin-β Receptor Fusion Protein, in Primary Sjögren’s Syndrome: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Trial

Arthritis & rheumatology (Hoboken, N.J.), 2018-07, Vol.70 (9), p.1470-1480

2018

Link zum Volltext

Verfügbarkeit prüfen

Costs and effects of higher turnover of nurses and Aboriginal health practitioners and higher use of short-term nurses in remote Australian primary care services: an observational cohort study

BMJ open, 2019-02, Vol.9 (2), p.e023906-e023906

2019

Link zum Volltext

Verfügbarkeit prüfen

Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes

Nature (London), 2023-11, Vol.623 (7987), p.616-624

2023

Link zum Volltext

Verfügbarkeit prüfen

Detection of FGF-β mRNA in chondrosacrcoma cells by a new in situ hybridization technique with synthetic oligonucleotide probes

Journal of biochemical and biophysical methods, 1991, Vol.22 (4), p.279-288

1991

Link zum Volltext

Verfügbarkeit prüfen

Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9

Bioorganic & medicinal chemistry, 2015-10, Vol.23 (19), p.6280-6296

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of turnover and stability of health staff on quality of care in remote communities of the Northern Territory, Australia: a retrospective cohort study

BMJ open, 2021-10, Vol.11 (10), p.e055635-e055635

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 85

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SeriePlos One

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(79)

Publikationsform

Artikel
(85)

Sprache

Englisch
(85)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

14‐3‐3 Protein Signaling in Development and Growth Factor Responses

14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell Survival

14-3-3:Shc Scaffolds Integrate Phosphoserine and Phosphotyrosine Signaling to Regulate Phosphatidylinositol 3-Kinase Activation and Cell SurvivalS

14-3-3[zeta] coordinates adipogenesis of visceral fat

14-3-3 Zeta is Required for Insulin Sensitivity and Glucose Homeostasis In Vivo

14-3-3zeta Regulates Adipogenesis, Glucose Tolerance and Insulin Sensitivity in Mice

14-3-3ζ coordinates adipogenesis of visceral fat

Abstract 5283: Elucidating a novel role for inositol polyphosphate 4-phosphatase type II (INPP4B) in mediating chemoresistance in acute myeloid leukemia

Abstract A19: The selective targeting of cell survival pathways in leukemia

Abstract B158: Targeting cell survival pathways in glioblastoma

Activation of protein phosphatase 2A in FLT3+ acute myeloid leukemia cells enhances the cytotoxicity of FLT3 tyrosine kinase inhibitors

Admixture mapping in lupus identifies multiple functional variants within IFIH1 associated with apoptosis, inflammation, and autoantibody production

Associations Between Rheumatoid Arthritis Clinical Factors and Synovial Cell Types and States

Blocking of Cytokine Survival Signals along with Intense Bcr-Abl Kinase Inhibition May Eradicate CML Progenitor Cells

CD123 (IL-3 Receptor α Chain) Neutralization by a Monoclonal Antibody Selectively Eliminates Human Acute Myeloid Leukemic Stem Cells

Characterization of a Low Molecular Weight Isoform of IL-1 Receptor Antagonist

The chromatin landscape of pathogenic transcriptional cell states in rheumatoid arthritis

Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome

Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial

The Clinical Efficacy and Safety of Baminercept, a Lymphotoxin-β Receptor Fusion Protein, in Primary Sjögren’s Syndrome: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Trial

Costs and effects of higher turnover of nurses and Aboriginal health practitioners and higher use of short-term nurses in remote Australian primary care services: an observational cohort study

Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes

Detection of FGF-β mRNA in chondrosacrcoma cells by a new in situ hybridization technique with synthetic oligonucleotide probes

Discovery and SAR of novel pyrazolo[1,5-a]pyrimidines as inhibitors of CDK9

Effects of turnover and stability of health staff on quality of care in remote communities of the Northern Territory, Australia: a retrospective cohort study

Aktive Filter

Suchergebnisse filtern